Evaluation of a Diagnostic Software for Coronary Artery Disease Using Retrospective CCTA Data (CODEX-1 Study)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstituto de Investigación Biomédica de Salamanca

About this trial

The CODEX-1 study is a multicenter retrospective observational study designed to assess the diagnostic performance of a novel software application for coronary artery disease (CAD) evaluation. The application integrates automated stenosis detection, CT-derived fractional flow reserve (CT-FFR), and plaque quantification, all performed on-site. A total of 1,000 patients who previously underwent coronary computed tomography angiography (CCTA) and diagnostic invasive coronary angiography (ICA) and/or other non-invasive imaging will be included. The study compares the diagnostic outputs of the software to current clinical practice and expert adjudication, focusing on CAD-RADS categorization, prediction of the need for percutaneous coronary intervention (PCI), and reduction in unnecessary ICA procedures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 years or older

Underwent coronary computed tomography angiography (CCTA) for the diagnosis or assessment of coronary artery disease (CAD) between 2019 and 2024

Availability of comparator diagnostic data within 1 month before or after the CCTA, such as: Invasive coronary angiography (ICA), Stress MRI, Alternative CCTA analysis software, Documented clinical events

Disqualifiers

None

Trial population

Retrospective cohort of 1,000 adult patients who underwent coronary computed tomography angiography (CCTA) between 2019 and 2024 for the diagnosis or assessment of coronary artery disease (CAD), at four academic hospitals in Spain, the Netherlands, and France. All patients have comparator diagnostic data available, such as invasive coronary angiography (ICA) and/or other non-invasive imaging. No new data collection or interventions will be performed, and all analyses will be conducted offline on de-identified datasets

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Diagnostic Software Application for CAD Assessment

    Device

    A novel on-premises diagnostic software integrating automated coronary stenosis detection, CT-derived fractional flow reserve (CT-FFR), and plaque quantification for evaluation of coronary artery disease (CAD) using coronary computed tomography angiography (CCTA) datasets.

Treatment groups

1,000 Participants
are divided into 1 treatment group
Group A: Cohort_11 intervention

Trial outcomes

Primary outcomes

1

Diagnostic accuracy of CAD-RADS classification using the diagnostic software

Accuracy of the CAD-RADS category assigned by the software compared to expert adjudication using invasive coronary angiography (ICA) and/or other non-invasive imaging.

Time frame
At study completion (expected March 2025)
2

Reproducibility of CAD-RADS classification using the diagnostic software

Assessment of inter-reader and intra-reader reproducibility in CAD-RADS classification using the software, evaluated via kappa statistics and intraclass correlation coefficients (ICC), stratified by reader experience.

Time frame
At study completion (expected March 2025)

Secondary outcomes

1

User satisfaction with the diagnostic software application

User satisfaction will be evaluated using a standardized 5-point Likert scale questionnaire completed by radiologists and cardiac imagers. The scale ranges from 1 (Very dissatisfied) to 5 (Very satisfied). Higher scores indicate greater satisfaction with the usability and performance of the software.

Time frame
After completion of image analysis (expected March 2025)
2

Accuracy of the software in predicting the need for percutaneous coronary intervention (PCI)

Comparison between PCI recommendations generated by the software application (based on CCTA and CT-FFR analysis) and actual PCI decisions made in clinical practice.

Time frame
At study completion (expected March 2025)
3

Proportion of invasive coronary angiographies (ICA) without PCI potentially avoidable based on software analysis

Percentage of ICA procedures not followed by PCI that could have been avoided based on retrospective evaluation with the diagnostic software.

Time frame
At study completion (expected March 2025)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.